Most gangliogliomas show molecular evidence of activation of the mitogen-activated protein kinase (MAPK) pathway, with the BRAF V600E as the most common alteration [8], and the most common chromosomal alteration is the gain of chromosome 7 [9]. This evidence concerns the gene WNK2 and ganglioglioma.